Belkis Unsal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Belkis Unsal has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Altay Kandemir
Adnan Menderes Üniversitesi
5 shared publications - Mustafa Çeli̇k
Department of Gastroenterology, Pamukkale University Training and Research Hospital, Denizli
5 shared publications - Sezgin Vatansever
Department of Gastroenterology, Katip Çelebi University Atatürk Research and Training Hospital, İzmir, Türkiye
4 shared publications - Emrah Alper
Division of Gastroenterology and Hepatology, Koc University School of Medicine, Istanbul, Turkey.
3 shared publications - Mehmet Haciyanli
Department of General Surgery, Izmir Kâtip Celebi University Ataturk Training and Research Hospital, Izmir, Türkiye
3 shared publications Behlül Baydar
2 shared publications
Latest Publications
- Open Access
- 30 November 2021
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 32 (12) , 1019-1028
Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study
Hepatocellular carcinoma,epidemiology,risk factors,prognostic factors,screening,Turkey
- 30 November 2021
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 32 (12) , 1019-1028
Open AccessCharacteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study
Hepatocellular carcinoma,epidemiology,risk factors,prognostic factors,screening,Turkey
- Open Access
- 20 September 2019
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 58 (3) , 246-250
Coexisting of coeliac disease in primary biliary cirrhosis
En tr Aim: Autoimmune disorders tend to show co-occurrence. Coeliac disease (CD) may accompany primary biliary cirrhosis (PBC) like other autoimmune diseases. In this study, we aimed to evaluate the prevalance of CD in PBC patients.Materials and Methods: Two hundred and thirty eight patients whom diagnosed as PBC between April 2006-December 2017 and 205 healthy volunteers as control group compared prospectively. AGA IgG, AGA IgA, EMA IgG and EMA IgA results evaluated. Duodenum biopsies were obtained in patients who had positive AGA an EMA results.Results: Median age was 54.2+12 in PBC patients and 43.8+14.4 in control group. Sixteeen of 238 PBC patients and 90 of 205 control were male. Four (1.7%) PBC patients had AGA and EMA positivity. None of PBC patients had symptoms for CD. Thirteen (5.46%) patients had AGA positivity with low titration. One (0.4%) healthy control had EMA and AGA positivity and there was no statistical difference between two groups (p=0.379). According to Marsh classification of duodenal biopsies we found one Marsh 1, one Marsh 2 and two Marsh 3 in PBS group. one control who had positive EMA and AGA results showed Marsh 3 in duodenal biopsies.Conclusion: PBC and CD may be associated. PBC patients who are seropositive for CD must be followed according to complications of CD. Gluten-free diet is required for these patients. Amaç: Otoimmun hastalıklar genel olarak birliktelik gösterme eğilimindendirler. Primer biliyer siroza (PBS) da diğer otoimmun hastalıkların yanı sıra çölyak hastalığı (ÇH) eşlik edebilmektedir. Bu çalışmada PBS’li hastalarda ÇH’nin prevalansı değerlendirildi. Yöntem ve Gereç: Çalışmaya Nisan 2006-Aralık 2017 tarihleri arasında tanı alan ve takipli olan 238 PBS’li hasta, kontrol grubu olarak alınan 205 sağlıklı gönüllü ile prospektif olarak karşılaştırıldı. Hastalarda Anti Gliadin IgA ve IgG (AGA), Anti Endomisyum IgA ve IgG (EMA) antikorları immunofloresans yöntemi ile bakıldı. Antikorları pozitif saptanan hastalardan duodenum ikinci kısmından biyopsi alındı. Bulgular: Çalışmaya alınan 238 hastanın yaş ortalaması 54,2 (±) 12 olup 16’sı erkekti. Kontrol grubundaki 205 kişinin 115’i kadın (%56,1), 90’ı erkek ve yaş ortalaması 43,8 (±) 14,4’tü. PBS’li 4 hastada AGA ve EMA pozitifliği (%1,7) saptandı. PBS’li hastaların hiçbirinde ÇH semptomları yoktu. On üç (%5,46) hastada ise düşük titrede AGA pozitifliği saptandı. Kontrol grubundaki bir (%0,4) hastada EMA, AGA IgA ve IgG yüksek titrede pozitif saptandı ve PBS’li grup ile istatistiksel fark saptanmadı (p=0,379). PBS tanısı olan ve EMA, AGA pozitif saptanan 4 hastanın biyopsisinde, 1 hastada Marsh 1, 1 hastada Marsh 2 ve 2 hastada Marsh 3 ile uyumlu duodenum biyopsi bulguları saptandı . EMA ve AGA’sı pozitif olan kontrol grubundaki bir hastanın ince barsak biyopsisi ise Marsh 3 ile uyumluydu. Sonuç: PBS ve ÇH, birbiri ile ilişkili olabilen hastalıklardır. PBS tanılı hastalarda, ÇH açısından seropozitif olan hastaların takibinin ÇH ve komplikasyonlarına de yönelik olması ve tanı konulan hastalara glutensiz diyetin başlanması gerekmektedir.
- 20 September 2019
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 58 (3) , 246-250
Open AccessCoexisting of coeliac disease in primary biliary cirrhosis
En tr Aim: Autoimmune disorders tend to show co-occurrence. Coeliac disease (CD) may accompany primary biliary cirrhosis (PBC) like other autoimmune diseases. In this study, we aimed to evaluate the prevalance of CD in PBC patients.Materials and Methods: Two hundred and thirty eight patients whom diagnosed as PBC between April 2006-December 2017 and 205 healthy volunteers as control group compared prospectively. AGA IgG, AGA IgA, EMA IgG and EMA IgA results evaluated. Duodenum biopsies were obtained in patients who had positive AGA an EMA results.Results: Median age was 54.2+12 in PBC patients and 43.8+14.4 in control group. Sixteeen of 238 PBC patients and 90 of 205 control were male. Four (1.7%) PBC patients had AGA and EMA positivity. None of PBC patients had symptoms for CD. Thirteen (5.46%) patients had AGA positivity with low titration. One (0.4%) healthy control had EMA and AGA positivity and there was no statistical difference between two groups (p=0.379). According to Marsh classification of duodenal biopsies we found one Marsh 1, one Marsh 2 and two Marsh 3 in PBS group. one control who had positive EMA and AGA results showed Marsh 3 in duodenal biopsies.Conclusion: PBC and CD may be associated. PBC patients who are seropositive for CD must be followed according to complications of CD. Gluten-free diet is required for these patients. Amaç: Otoimmun hastalıklar genel olarak birliktelik gösterme eğilimindendirler. Primer biliyer siroza (PBS) da diğer otoimmun hastalıkların yanı sıra çölyak hastalığı (ÇH) eşlik edebilmektedir. Bu çalışmada PBS’li hastalarda ÇH’nin prevalansı değerlendirildi. Yöntem ve Gereç: Çalışmaya Nisan 2006-Aralık 2017 tarihleri arasında tanı alan ve takipli olan 238 PBS’li hasta, kontrol grubu olarak alınan 205 sağlıklı gönüllü ile prospektif olarak karşılaştırıldı. Hastalarda Anti Gliadin IgA ve IgG (AGA), Anti Endomisyum IgA ve IgG (EMA) antikorları immunofloresans yöntemi ile bakıldı. Antikorları pozitif saptanan hastalardan duodenum ikinci kısmından biyopsi alındı. Bulgular: Çalışmaya alınan 238 hastanın yaş ortalaması 54,2 (±) 12 olup 16’sı erkekti. Kontrol grubundaki 205 kişinin 115’i kadın (%56,1), 90’ı erkek ve yaş ortalaması 43,8 (±) 14,4’tü. PBS’li 4 hastada AGA ve EMA pozitifliği (%1,7) saptandı. PBS’li hastaların hiçbirinde ÇH semptomları yoktu. On üç (%5,46) hastada ise düşük titrede AGA pozitifliği saptandı. Kontrol grubundaki bir (%0,4) hastada EMA, AGA IgA ve IgG yüksek titrede pozitif saptandı ve PBS’li grup ile istatistiksel fark saptanmadı (p=0,379). PBS tanısı olan ve EMA, AGA pozitif saptanan 4 hastanın biyopsisinde, 1 hastada Marsh 1, 1 hastada Marsh 2 ve 2 hastada Marsh 3 ile uyumlu duodenum biyopsi bulguları saptandı . EMA ve AGA’sı pozitif olan kontrol grubundaki bir hastanın ince barsak biyopsisi ise Marsh 3 ile uyumluydu. Sonuç: PBS ve ÇH, birbiri ile ilişkili olabilen hastalıklardır. PBS tanılı hastalarda, ÇH açısından seropozitif olan hastaların takibinin ÇH ve komplikasyonlarına de yönelik olması ve tanı konulan hastalara glutensiz diyetin başlanması gerekmektedir.
- 15 August 2019
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 30 (8) , 673-679
Role of endoscopic interventions and electroincision in benign anastomotic strictures following colorectal surgery
Background/Aims: The anastomotic strictures are one of the most common colorectal surgery complications, and various endoscopic techniques have been defined. Balloon dilation is the most well-known and the simplest procedure. In this article, we aimed to present our series of endoscopic interventions and electroincision management for anastomotic strictures. Materials and Methods: The files of 59 patients, who underwent colorectal surgery between January 2010 and September 2017 in our hospital and were diagnosed during the follow-up with anastomotic stricture, were analyzed. The outcomes of endoscopic interventions such as balloon dilation and electroincision were compared and reported. Results: The mean age of the 59 patients included in the study was 59.5±16.26 years. The primary operative indications were colorectal cancer in 46, inflammatory bowel disease in 7, diverticulum in 5, and penetrating trauma in one patient. Single- or multiple-balloon dilations were successful in 48 patients. Electroincision was performed in 11 patients because of the balloon dilation failure. None of the patients needed a secondary surgery. During the mean 33.75 months of the follow-up, the stricture recurred in seven patients who had undergone balloon dilation. Repeated balloon dilation was successful in these patients without any need for an additional surgical intervention. Conclusion: Balloon dilation can be performed safely as the primary treatment option, because of its easy access and noninvasive application. Electroincision is also a safe and effective endoscopic technique that can be preferred especially when the balloon dilation fails.
- 15 August 2019
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 30 (8) , 673-679
Role of endoscopic interventions and electroincision in benign anastomotic strictures following colorectal surgery
Background/Aims: The anastomotic strictures are one of the most common colorectal surgery complications, and various endoscopic techniques have been defined. Balloon dilation is the most well-known and the simplest procedure. In this article, we aimed to present our series of endoscopic interventions and electroincision management for anastomotic strictures. Materials and Methods: The files of 59 patients, who underwent colorectal surgery between January 2010 and September 2017 in our hospital and were diagnosed during the follow-up with anastomotic stricture, were analyzed. The outcomes of endoscopic interventions such as balloon dilation and electroincision were compared and reported. Results: The mean age of the 59 patients included in the study was 59.5±16.26 years. The primary operative indications were colorectal cancer in 46, inflammatory bowel disease in 7, diverticulum in 5, and penetrating trauma in one patient. Single- or multiple-balloon dilations were successful in 48 patients. Electroincision was performed in 11 patients because of the balloon dilation failure. None of the patients needed a secondary surgery. During the mean 33.75 months of the follow-up, the stricture recurred in seven patients who had undergone balloon dilation. Repeated balloon dilation was successful in these patients without any need for an additional surgical intervention. Conclusion: Balloon dilation can be performed safely as the primary treatment option, because of its easy access and noninvasive application. Electroincision is also a safe and effective endoscopic technique that can be preferred especially when the balloon dilation fails.
- 15 April 2019
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 30 (Supplement) , S913-S944
2019 Expert opinion on biological treatment use in inflammatory bowel disease management
Cite this article as: Törüner M, Akpınar H, Akyüz F, et al. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management. Turk J Gastroenterol 2019; 30(Suppl 4): S913-46.
- 15 April 2019
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 30 (Supplement) , S913-S944
2019 Expert opinion on biological treatment use in inflammatory bowel disease management
Cite this article as: Törüner M, Akpınar H, Akyüz F, et al. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management. Turk J Gastroenterol 2019; 30(Suppl 4): S913-46.
- 24 September 2018
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 17 (2) , 45-49
The Utility of M30 and M65 Antigen Concentration Levels for Predicting Degree of Hepatic Injury in Patients with Chronic Hepatitis B Infection
Background and aims: We aimed to determine the utility of M30 and M65 antigen concentration levels for predicting hepatic injury in chronic hepatitis B disease.Materials and Methods: This study compared concentration levels of M30 and M65 antigens between patients with hepatitis B e-antigen negative chronic hepatitis B and healthy subjects. Furthermore, the correlations between either M30 or M65 antigen levels and aspartate aminotransferase, alanine aminotransferase, HBV-DNA, histological activity index and fibrosis were evaluated in the patient group.Results: A total of 81 subjects were included in the study; 50 patients with HBeAg negative chronic hepatitis B and 31 healthy subjects. The concentration of the M30 antigen was significantly higher in the chronic hepatitis B patient group than in the healthy subject group (p 0.05). Correlation analysis performed in the patient group revealed a significant correlation between M30 antigen concentration levels and aspartate aminotransferase levels (r: 0.207, p <0.05), and between M65 antigen concentration levels and HBV-DNA levels (r: 0.204, p <0.05). There was no significant correlation observed between M30 or M65 antigen concentration levels and both the histological activity index and fibrosis. Discussion: The presence of high M30 antigen levels in HBeAg negative chronic hepatitis B patients may suggest that M30 antigen concentration might be beneficial in disease monitoring and evaluation of treatment efficacy. This observation must be tested further in more comprehensive studies. However, the absence of a significant correlation between the concentration levels of either antigen or both the histological activity index and fibrosis suggests that pathological examination is unique in detecting hepatic injury.
- 24 September 2018
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 17 (2) , 45-49
The Utility of M30 and M65 Antigen Concentration Levels for Predicting Degree of Hepatic Injury in Patients with Chronic Hepatitis B Infection
Background and aims: We aimed to determine the utility of M30 and M65 antigen concentration levels for predicting hepatic injury in chronic hepatitis B disease.Materials and Methods: This study compared concentration levels of M30 and M65 antigens between patients with hepatitis B e-antigen negative chronic hepatitis B and healthy subjects. Furthermore, the correlations between either M30 or M65 antigen levels and aspartate aminotransferase, alanine aminotransferase, HBV-DNA, histological activity index and fibrosis were evaluated in the patient group.Results: A total of 81 subjects were included in the study; 50 patients with HBeAg negative chronic hepatitis B and 31 healthy subjects. The concentration of the M30 antigen was significantly higher in the chronic hepatitis B patient group than in the healthy subject group (p 0.05). Correlation analysis performed in the patient group revealed a significant correlation between M30 antigen concentration levels and aspartate aminotransferase levels (r: 0.207, p <0.05), and between M65 antigen concentration levels and HBV-DNA levels (r: 0.204, p <0.05). There was no significant correlation observed between M30 or M65 antigen concentration levels and both the histological activity index and fibrosis. Discussion: The presence of high M30 antigen levels in HBeAg negative chronic hepatitis B patients may suggest that M30 antigen concentration might be beneficial in disease monitoring and evaluation of treatment efficacy. This observation must be tested further in more comprehensive studies. However, the absence of a significant correlation between the concentration levels of either antigen or both the histological activity index and fibrosis suggests that pathological examination is unique in detecting hepatic injury.
- 24 April 2018
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 17 (1) , 28-32
Changes in serum levels of cytokeratin-18 fragments in patients with chronic hepatitis C under antiviral therapy
Background and Aims: Cytokeratin-18 is the known substrate for caspases, which are encountered during hepatic and pancreatic acinar apoptosis. Studies performed in recent years have indicated that the cleavage level of serum cytokeratin-18 (M30 antigen) is correlated with hepatic fibrosis and disease severity in both chronic hepatitis C and non-alcoholic steatohepatitis. It was shown that antiviral therapy in chronic viral hepatitis C patients significantly reduced hepatocellular apoptosis and cytokeratin-18 is accepted as a reliable marker of hepatocyte apoptosis. Our aim was to determine the correlation between the cytokeratin-18 level and treatment response in patients with chronic viral hepatitis C. Materials and Methods: Sixty patients with chronic viral hepatitis C were included in the study. A 48-week course of peginterferon- ribavirin therapy was given to appropriate patients. Hepatitis C virus RNA was measured at 0, 12, and 24 weeks at the end of therapy and 72 weeks. In addition, cytokeratin-18 levels were measured at 0, 24, and 72 weeks. Results: The mean age of 60 patients was 52±10.9 years. While 31 (51.6%) of patients were in the sustained viral response group, 29 (8.4%) of patients were in the non-sustained viral response group. It was determined that while the cytokeratin-18 level at week 0 in the sustained viral response group was 243±21, the cytokeratin-18 level at week 24 was 115±12 U/L and the difference between the level of cytokeratin-18 at weeks 0 and 24 were 127±209 U/L (p: .014). While the cytokeratin-18 level at week 0 in the non- sustained viral response group was 270±14; at week 24, the cytokeratin-18 level was 136±19 U/L and the difference between cytokeratin-18 levels at weeks 0 and 24 was 136±156 U/L (p > .5). At week 72, the cytokeratin-18 level in the sustained viral response group was 109±38 and the difference between weeks 0 and 72 was 134±215 (p < .002). Conclusion: In chronic viral hepatitis C patients, there was a correlation between sustained viral response and cytokeratin-18, which is a marker of apoptosis. During treatment, it was found that there was a relationship between sustained viral response and the decrease in cytokeratin-18 levels. Thisfinding indicates that cytokeratin-18 level monitoring may be used as a predictive marker of sustained viral response.
- 24 April 2018
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 17 (1) , 28-32
Changes in serum levels of cytokeratin-18 fragments in patients with chronic hepatitis C under antiviral therapy
Background and Aims: Cytokeratin-18 is the known substrate for caspases, which are encountered during hepatic and pancreatic acinar apoptosis. Studies performed in recent years have indicated that the cleavage level of serum cytokeratin-18 (M30 antigen) is correlated with hepatic fibrosis and disease severity in both chronic hepatitis C and non-alcoholic steatohepatitis. It was shown that antiviral therapy in chronic viral hepatitis C patients significantly reduced hepatocellular apoptosis and cytokeratin-18 is accepted as a reliable marker of hepatocyte apoptosis. Our aim was to determine the correlation between the cytokeratin-18 level and treatment response in patients with chronic viral hepatitis C. Materials and Methods: Sixty patients with chronic viral hepatitis C were included in the study. A 48-week course of peginterferon- ribavirin therapy was given to appropriate patients. Hepatitis C virus RNA was measured at 0, 12, and 24 weeks at the end of therapy and 72 weeks. In addition, cytokeratin-18 levels were measured at 0, 24, and 72 weeks. Results: The mean age of 60 patients was 52±10.9 years. While 31 (51.6%) of patients were in the sustained viral response group, 29 (8.4%) of patients were in the non-sustained viral response group. It was determined that while the cytokeratin-18 level at week 0 in the sustained viral response group was 243±21, the cytokeratin-18 level at week 24 was 115±12 U/L and the difference between the level of cytokeratin-18 at weeks 0 and 24 were 127±209 U/L (p: .014). While the cytokeratin-18 level at week 0 in the non- sustained viral response group was 270±14; at week 24, the cytokeratin-18 level was 136±19 U/L and the difference between cytokeratin-18 levels at weeks 0 and 24 was 136±156 U/L (p > .5). At week 72, the cytokeratin-18 level in the sustained viral response group was 109±38 and the difference between weeks 0 and 72 was 134±215 (p < .002). Conclusion: In chronic viral hepatitis C patients, there was a correlation between sustained viral response and cytokeratin-18, which is a marker of apoptosis. During treatment, it was found that there was a relationship between sustained viral response and the decrease in cytokeratin-18 levels. Thisfinding indicates that cytokeratin-18 level monitoring may be used as a predictive marker of sustained viral response.
- 1 June 2013
- Vol. 60 (124) , 678-83
The use of radial endosonography findings in the prediction of cholangiocarcinoma in cases with distal bile duct obstructions.
We retrospectively collected the data of radial endosonographic (EUS) imaging findings of the patients with the distal bile duct obstructions due to different benign and malignant conditions. We aimed to assess and analyze the EUS findings in the distal bile duct obstruction which can predict or detect the existence of cholangiocarcinoma originating from the distal bile duct wall. We gathered the data of 192 cases with distal biliary stricture due to various causes which all were diagnosed. With EUS, The sensitivity and specificity for diagnosis of cholangiocarcinoma in lesions were respectively as following: Firstly, small hypoechoic mass which interrupts to see lumen and choledoch wall with total occlusion at distal choledoch: 75.8%, 88.1%. Secondly, hypoechoic and irregular thickening than surrounding regions at distal choledoch wall: 68.1%, 87.3%. Thirdly, appearance of lumen prompt termination at distal choledoch: 57.1%, 87.6%. Lastly, appearance where lumen narrows short segment: 13.6 %, 59.3 %. EUS findings including hypoechoic mass appearance completely occluding the lumen or heterogeneously increased irregular wall-thickness in the distal bile duct were found to be highly predictive and sensitive for detecting malignancy originating from the distal bile duct.
- 1 June 2013
- Vol. 60 (124) , 678-83
The use of radial endosonography findings in the prediction of cholangiocarcinoma in cases with distal bile duct obstructions.
We retrospectively collected the data of radial endosonographic (EUS) imaging findings of the patients with the distal bile duct obstructions due to different benign and malignant conditions. We aimed to assess and analyze the EUS findings in the distal bile duct obstruction which can predict or detect the existence of cholangiocarcinoma originating from the distal bile duct wall. We gathered the data of 192 cases with distal biliary stricture due to various causes which all were diagnosed. With EUS, The sensitivity and specificity for diagnosis of cholangiocarcinoma in lesions were respectively as following: Firstly, small hypoechoic mass which interrupts to see lumen and choledoch wall with total occlusion at distal choledoch: 75.8%, 88.1%. Secondly, hypoechoic and irregular thickening than surrounding regions at distal choledoch wall: 68.1%, 87.3%. Thirdly, appearance of lumen prompt termination at distal choledoch: 57.1%, 87.6%. Lastly, appearance where lumen narrows short segment: 13.6 %, 59.3 %. EUS findings including hypoechoic mass appearance completely occluding the lumen or heterogeneously increased irregular wall-thickness in the distal bile duct were found to be highly predictive and sensitive for detecting malignancy originating from the distal bile duct.
- 1 May 2013
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 60 (123) , 595-600
Hepcidin as a predictor of disease severity in acute pancreatitis: a single center prospective study.
Predicting the severity of acute pancreatitis is limited to clinical, laboratory and radiological risk factors. Hepcidin levels increase in acute inflammation. We aimed to assess the relationship between hepcidin and C-reactive protein (CRP), white blood cells (WBC) and multi-detector computerized tomography (MDCT) in predicting the severity of pancreatitis. We undertook a prospective review of 59 consecutive patients with acute pancreatitis admitted to our clinic. Biochemical values were measured from blood samples taken within 2 hours of admission and from between 2 and 72 hours related to the time of symptom onset. In predicting severe acute pancreatitis, hepcidin was superior to CRP and WBC (Area Under the Curve (AUC)=0.79, p=0.003; AUC=0.69, p=NS; AUC=0.53, p=NS, respectively). In this study, hepcidin was found to be superior to CRP in predicting the severity of pancreatitis.
- 1 May 2013
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 60 (123) , 595-600
Hepcidin as a predictor of disease severity in acute pancreatitis: a single center prospective study.
Predicting the severity of acute pancreatitis is limited to clinical, laboratory and radiological risk factors. Hepcidin levels increase in acute inflammation. We aimed to assess the relationship between hepcidin and C-reactive protein (CRP), white blood cells (WBC) and multi-detector computerized tomography (MDCT) in predicting the severity of pancreatitis. We undertook a prospective review of 59 consecutive patients with acute pancreatitis admitted to our clinic. Biochemical values were measured from blood samples taken within 2 hours of admission and from between 2 and 72 hours related to the time of symptom onset. In predicting severe acute pancreatitis, hepcidin was superior to CRP and WBC (Area Under the Curve (AUC)=0.79, p=0.003; AUC=0.69, p=NS; AUC=0.53, p=NS, respectively). In this study, hepcidin was found to be superior to CRP in predicting the severity of pancreatitis.
- 1 May 2013
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 77 (5) , AB561
Tu1497 Comparison of Jumbo Biopsy Forceps and Standard Biopsy Forceps in the Treatment of Small Colon Polyps
- 1 May 2013
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 77 (5) , AB561
Tu1497 Comparison of Jumbo Biopsy Forceps and Standard Biopsy Forceps in the Treatment of Small Colon Polyps
- 1 May 2013
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 77 (5) , AB547
Tu1457 Large Polyps Are a Great Problem! Endoscopic Treatment Versus Surgical Treatment
- 1 May 2013
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 77 (5) , AB547
Tu1457 Large Polyps Are a Great Problem! Endoscopic Treatment Versus Surgical Treatment